Showing results (31-40 of 496) with videos related to
Sort By:
Pageof 50
The New England Journal of Medicine|August 16, 2013
Long-term survival of participants in the prostate cancer prevention trialIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.The Journal of Urology|October 22, 2008
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794Gregory P Swanson, Bryan Goldman, Catherine M Tangen, et al.The Prostate|July 12, 2008
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trialMarian L Neuhouser, Jeannette Schenk, Yoon Ju Song, et al.Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794Gregory P Swanson, Michael A Hussey, Catherine M Tangen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.JAMA Oncology|January 1, 2016
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate CancerDawn L Hershman, Joseph M Unger, Jason D Wright, et al.Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.Frontiers in Oncology|January 31, 2022
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialZhihong Gong, Mary E Platek, Cathee Till, et al.Kidney Cancer (Clifton, Va.)|October 19, 2018
Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107Przemyslaw W Twardowski, Catherine M Tangen, Xiwei Wu, et al.Pageof 50